Daily Technical Analysis Weekly Analysis Monthly Analysis Renko chart MACD chart Bollinger Bands chart Stochastics charts Force Index charts

(GLAXO) Glaxosmithkline Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Glaxosmithkline Pharmaceuticals | (GLAXO) share price targets

Complete technical analysis of Glaxosmithkline Pharmaceuticals (GLAXO) by charts plus indicators, forecast predictions and share price targets for Glaxosmithkline Pharmaceuticals (GLAXO)

Glaxosmithkline Pharmaceuticals trades in NSE in Pharmaceuticals sector.

Showing technical analysis as on 2024-12-31 View latest technical analysis

10 day averaged volume of Glaxosmithkline Pharmaceuticals is 79066

Date	Daily Closing Price	Open	High	Low	Volume
31 Tue Dec 2024	2251.85	2190.10	2265.45	2158.40	1.574 times
30 Mon Dec 2024	2187.75	2274.45	2280.15	2162.75	2.786 times
27 Fri Dec 2024	2274.45	2243.20	2284.20	2241.00	0.51 times
26 Thu Dec 2024	2243.20	2264.60	2274.95	2213.40	0.3 times
24 Tue Dec 2024	2264.60	2266.00	2287.95	2243.00	0.574 times
23 Mon Dec 2024	2282.75	2275.95	2292.65	2225.00	0.533 times
20 Fri Dec 2024	2275.95	2325.00	2326.30	2264.00	1.081 times
19 Thu Dec 2024	2326.30	2315.00	2337.00	2286.25	1 times
18 Wed Dec 2024	2332.55	2285.00	2339.50	2270.10	1.274 times
17 Tue Dec 2024	2264.95	2278.60	2298.65	2253.40	0.939 times

My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 2248.2 as stoploss in an intra day buy trade for a target of 2304.61. However, stock will show a bearish move below 2248.2.

Share price targets for Glaxosmithkline Pharmaceuticals (GLAXO)

Target Type	Value
Downside Target	2158.40
Downside Target	2213.40
Upside Target	2457.75
Upside Target	2500.00
Upside Target	2676.25
Upside Target	2702.10
Upside Target	2742.95
Upside Target	2889.90
Upside Target	2922.80
Upside Target	3088.00

Intraday share price targets for Glaxosmithkline Pharmaceuticals (GLAXO)

Target Type	Value
Downside Intraday Target	2180.12
Downside Intraday Target	2108.38
Upside Intraday Target	2301.87
Upside Intraday Target	2351.88
Downside Intraday Target	2230.13

Weekly technical analysis of Glaxosmithkline Pharmaceuticals (GLAXO)

Date	Weekly Closing Price	Open	High	Low	Volume
31 Tue Dec 2024	2251.85	2274.45	2280.15	2158.40	2.275 times
27 Fri Dec 2024	2274.45	2275.95	2292.65	2213.40	0.362 times
20 Fri Dec 2024	2275.95	2255.55	2339.50	2229.00	1.251 times
13 Fri Dec 2024	2254.00	2343.15	2379.90	2250.30	0.665 times
06 Fri Dec 2024	2343.15	2436.00	2457.75	2333.00	0.883 times

Price has moved down this week, and volume has increased substantially. This means that the move can continue in coming weeks.

Monthly technical analysis of Glaxosmithkline Pharmaceuticals (GLAXO)

Date	Monthly Closing Price	Open	High	Low	Volume
31 Tue Dec 2024	2251.85	2436.00	2457.75	2158.40	0.973 times
29 Fri Nov 2024	2444.40	2729.00	2742.95	2307.00	0.867 times
31 Thu Oct 2024	2712.25	2751.00	2889.90	2500.00	1.386 times
30 Mon Sep 2024	2750.55	2751.85	2922.80	2676.25	0.476 times

Scroll below to view daily charts

Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.

Indicators analysis of Glaxosmithkline Pharmaceuticals (GLAXO)

Price action analysis of Glaxosmithkline Pharmaceuticals ( (GLAXO) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small

Price action analysis of Glaxosmithkline Pharmaceuticals ( (GLAXO) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

Price action analysis of Glaxosmithkline Pharmaceuticals ( (GLAXO) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

Price action analysis of Glaxosmithkline Pharmaceuticals ( (GLAXO) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

ADX buy sell signal for Glaxosmithkline Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.

MACD generated a BUY signal for Glaxosmithkline Pharmaceuticals in short term but the buy signal is initial and weak.

MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

Glaxosmithkline Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up

CCI has generated a buy signal for Glaxosmithkline Pharmaceuticals in short term but BUY signal is weak.

RSI is generating a SELL signal in short term but selling is losing momentum.

MRSI is in negative zone. This is the SELL zone

Although the stock is in the SELL zone, but selling might be slowing down

Stock of Glaxosmithkline Pharmaceuticals is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 2258.45 and Glaxosmithkline Pharmaceuticals (GLAXO) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Glaxosmithkline Pharmaceuticals (GLAXO) stock. Volume based technical analysis of Glaxosmithkline Pharmaceuticals (GLAXO) stock is negative.

Glaxosmithkline Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.